Smartphone App Helps Diagnose Male Infertility Smartphone App Helps Diagnose Male Infertility
A smartphone app that measures sperm count and motility could help assess male fertility, aid vasectomy follow-up care.Medscape Medical News
In 2012, the American Urological Association published vasectomy guidelines to guide clinicians in best practices. Here we assess practice patterns of post-vasectomy semen analyses (PVSA) in a large, community cohort.
500,000 men in the US undergo vasectomy annually. About 6% will change their mind. 2 options to conceive are vasectomy reversal (VR) or sperm retrieval (SR) with in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI). Often the male partner is only evaluated by a urologist and counseled and treated with a VR without an evaluation or counseling of the female, or the female is evaluated by a reproductive endocrinologist (RE) on the option of IVF/ICSI, and the male partner is referred to a urologist to perform SR for use with IVF/ICSI.
We report the early learning curve results for VR performed by a single surgeon who had a fellowship with extensive MIM training.
The objectives of this study were to review the learning curve, complications and outcomes of the first 80 cases of microsurgical vasectomy reversal performed in a developing country (South Africa).
The microscopic sperm in vasal fluid at time of vasectomy reversal is associated with improved fertility outcomes. Several sperm specific proteins in seminal fluid have been proposed as potential biomarkers of obstructive azoospermia. Our goal was to evaluate sperm specific proteins and microscopic sperm presence in vasal fluid at time of vasectomy reversal.
Hospitals and surgeons are increasing accountable for resource utilization and cost. Specialized microsurgical sutures contribute significantly towards the cost of a vasectomy reversal (VR). Objective: To compare case costs and surgical outcomes following microsurgical vasectomy reversal between two different manufactures of 10-0 microsurgical sutures.
For over a decade, no studies have compared fertility outcomes between vasectomy reversal (VR) and in vitro fertilization (IVF) with intracytoplasmic sperm injection for older couples seeking a biologic child. We sought to provide pregnancy rates from a contemporary series of VR in men with female partners 35 years and older, and to correlate the results with pregnancy rates via IVF for women 35 years and older.
The American Urological Association (AUA) vasectomy guidelines published in October of 2012 outlined the criteria for vasectomy success as either azoospermia or rare non-motile sperm (RNMS) defined as ≤100,000 non-motile sperm/mL. Single-institution studies with stringent azoospermia-only criteria for vasectomy success have demonstrated that inclusion of RNMS in their criteria resulted in less laboratory testing. We sought to characterize nationwide practice patterns surrounding vasectomy follo w-up before and after publication of the 2012 guidelines.
To use the Truven Health MarketScan ® (THM) database to better approximate the annual rate of vasectomies performed in the US population, determine changes over time, regional differences, providers performing this, and if there is any monthly variation in vasectomy rates.
This study aims to evaluate whether cancer treatments differ in infertile men compared to men who have undergone vasectomy and age‐matched controls. We analyzed subjects from the Truven Health MarketScan Claims database from 2001 to 2009. Infertile men were identified through diagnosis and treatment codes. Comparison groups included vasectomized men and an age‐matched cohort who were not infertile and had not undergone vasectomy. We considered cancer types previously associated with infertility that were diagnosed after the diagnosis of infertility. The treatment regimens were determined based on the presence of claims...